每日一文(October)

Oct 31,2001 Effects of antihypertensive drugs on vascular remodeling

In the present review, the evidence that vasculoprotective properties of some antihypertensive drugs may predict improved outcomes in hypertensive patients is discussed.

Oct 30,2001 Disease Maps of the Human Genome-11

CHROMOSOME 11: Disease Gene Assignments, Selected References, Testing Sites

Oct 29,2001 Disease Maps of the Human Genome-10

CHROMOSOME 10: Disease Gene Assignments, Selected References, Testing Sites

Oct 28,2001 Differentiation Genes- Are They Primary Targets for Human Carcinogenesis

In spite of extensive research in molecular carcinogenesis, genes that can be considered primary targets in human carcinogenesis remain to be identified. Mutated oncogenes or cellular growth regulatory genes, when incorporated into normal human epithelial cells, failed to immortalize or transform these cells. Therefore, they may be secondary events in human carcinogenesis. such as melanoma, pheochromocytoma, medulloblastoma, glioma, sarcoma, and colon cancer.

Oct 27,2001 Dendritic cell vaccines for cancer therapy

Dendritic cells (DC) are professional antigen-presenting cells whose primary function is the initiation of immune response. Based on the finding that the immune system usually fails to identify and kill cancer cells, DC have been recently used as vaccines for stimulation of tumour-specific immunity. This review focuses on pitfalls related to DC-based vaccination against solid tumours and on improvement of this immunotherapeutic approach for routine treatment of cancer disease.

Oct 26,2001 Cytokines and hormones with anti-inflammatory effects- new tools for therapeutic intervention

The inflammation that is involved in the development of glomerulonephritis is tightly regulated by the expression of antiinflammatory factors. These include circulating hormones, such as glucocorticoids, and mediators that are produced by intrinsic cells and infiltrating leucocytes. The present review focuses on these anti-inflammatory factors, summarizing in particular their activities in existing models of glomerulonephritis. In addition, experimental evidence is presented that anti-inflammatory mediators are able to increase glucocorticoid binding or signalling in target cells. These data help to explain the in-vivo efficacy of anti-inflammatory mediators, and offer a promising new avenue for therapeutic intervention.

Oct 25,2001 Conditional transgenic technologies

Transgenic technology has been revolutionised by the development of techniques that allow temporo-spatial control of gene deletion or expression in transgenic animals. The ability to switch gene expression ‘on’ or ‘off' in restricted tissues at specific times allows unprecedented flexibility for exploring gene function in both health and disease.

Oct 24,2001 FOUNTAIN: A JAVA open-source package to assist large sequencing projects

A simple, but flexible and scalable software package is presented to facilitate data generation and storage for large sequencing projects. Open source and largely platform and database independent, we wish FOUNTAIN to be improved and extended in a community effort.

Oct 23,2001 Capecitabine: a novel agent for the treatment of solid tumors

This paper reviews the clinical use of 5-FU in the treatment of solid tumors, and discusses strategies for improving the efficacy and safety of 5-FU. It also discusses the developing role of the oral fluoropyrimidine capecitabine, a novel fluoropyrimidine carbamate that generates 5-FU preferentially in tumor tissue.

Oct 22,2001 Nuclear domains

The mammalian cell nucleus is a membrane-bound organelle that contains the machinery essential for gene expression. Although early studies suggested that little organization exists within this compartment, more contemporary studies have identified an increasing number of specialized domains or subnuclear organelles within the nucleus.

Oct 21,2001 Antioxidant Therapy: A New Pharmacological Approach in Shock, Inflammation, and Ischemia-Reperfusion Injury

A vast amount of circumstantial evidence implicates oxygen-derived free radicals (especially superoxide and hydroxyl radical) and high-energy oxidants (such as peroxynitrite) as mediators of inflammation, shock, and ischemia/reperfusion injury.

Oct 20,2001 Angiotensin II type 2 receptors: signalling and pathophysiological role
In recent years, studies, first in cell culture models but now increasingly also in vivo, have shed some light on the molecular events occurring after a stimulation of the receptor with its ligand as well as on its physiological effects and its significance for pathophysiological processes.
Oct 19,2001 Alzheimer's Disease- Genes, Proteins, and Therapy

Rapid progress in deciphering the biological mechanism of Alzheimer’s disease (AD) has arisen from the application of molecular and cell biology to this complex disorder of the limbic and association cortices. In turn, new insights into fundamental aspects of protein biology have resulted from research on the disease.

Oct 18,2001 Abundant protein domains occur in proportion to proteome size

Conserved domains in proteins have crucial roles in protein interactions, DNA binding, enzyme activity and other important cellular processes. It will be of interest to determine the proportions of genes containing such domains in the proteomes of different eukaryotes.

Oct 17,2001 A rapid method to map mutations in Drosophila

Genetic screens in Drosophila have provided a wealth of information about a variety of cellular and developmental processes. It is now possible to screen for mutant phenotypes in virtually any cell at any stage of development by performing clonal screens using the flp/FRT system.

Oct 16,2001 A Proteomic View on Genome-Based Signal Peptide Predictions

The availability of complete genome sequences has allowed the prediction of all exported proteins of the corresponding organisms with dedicated algorithms.Even though numerous studies report on genome-based predictions of signal peptides and cell retention signals, they lack a proteomic verification.

Oct 15,2001 A new job for dendritic cell
Dendritic cells can prime native lymphocytes. New data show how dendritic cells provide early activation cues by expression of IL-2, which may greatly enhance both T and B cell responses.
Oct 14,2001 A genomic timescale for the origin of eukaryotes

Genomic sequence analyses have shown that horizontal gene transfer occurred during the origin of eukaryotes as a consequence of symbiosis. However, details of the timing and number of symbiotic events are unclear.

Oct 13,2001

A conserved mechanism for post-transcriptional gene silencing?

Proteins with homology to RNA-directed RNA polymerases function in post-transcriptional gene silencing: in quelling in the fungus Neurospora crassa, RNAi in the nematode Caenorhabditis elegans, and co-suppression in the mustard plant Arabidopsis thaliana.

Oct 12,2001 Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols
  Development of effective chemopreventive agents against prostate cancer (CaP) for humans requires conclusive evidence of their efficacy in animal models that closely emulates human disease.
Oct 11,2001 The TSH receptor and its role in thyroid disease
  The thyrotropin (TSH) receptor plays a preeminent role in thyroid physiology and disease. TSH, acting through the TSH receptor, is the major stimulator of thyroid cell growth, differentiation and function.
Oct 10,2001 Transcription factor GATA3 and the human HDR syndrome
 

Recently, a member of the GATA-binding family of transcription factors was shown to be involved in the human hypoparathyroidism, sensorineural deafness and renal anomalies (HDR) syndrome.

Oct 09,2001 HLA and AIDS: a cautionary tale
 

The human major histocompatibility complex HLA has been implicated repeatedly as a regulator of the outcome of HIV exposure and infection. A new study of long-term survivors who naturally depress HIV-1 replication and avoid the signs of AIDS for years after infection suggests that homozygosity for a group of HLA-Blocus alleles termed Bw4confers resistance, ostensibly by regulating natural killer cell–ligand interactions. However, close inspection of the accumulated evidence raises some questions and urges validation of the potential Bw4effects in additional studies.

Oct 08,2001 High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain
  Neural stem and precursor cells reside in the ventricular lining of the fetal forebrain, and may provide a cellular substrate for brain repair. To selectively identify and extract these cells, we infected dissociated fetal human brain cells with adenoviruses bearing the gene for green fluorescence protein (GFP), placed under the control of enhancer/promoters for two genes (nestin and musashi1) that are expressed in uncommitted neuroepithelial cells.
Oct 07,2001 Hepatitis C viral RNA: challenges and promises
 

Hepatitis C virus (HCV), a positive-sense, single-stranded RNA virus of the Flaviviridae family, is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide.

Oct 06,2001 Hematologic Malignancies
This article reviews highlights in the field of hematologic malignancies presented at the 2001 annual meeting of the American Society of Clinical Oncology. Targeted therapies continue to proceed from the laboratory to the clinic.
Oct 05,2001 Glycan-dependent signaling: O-linked N-acetylglucosamine
The addition of O-linked N-acetylglucosamine (O-GlcNAc) to target proteins may serve as a signaling modification analogous to protein phosphorylation. Like phosphorylation, O-GlcNAc is a dynamic modification occurring in the nucleus and cytoplasm.
Oct 04,2001 Genotype transposer: automated genotype manipulation for linkage disequilibrium analysis
The purpose of this work is to provide the modern molecular geneticist with tools to perform more efficient and more accurate analysis of the genotype data they produce.
Oct 03,2001 Genes, proteins and brain disease
The genetic picture of Alzheimer’s disease (AD) is complex, explained R.E. Tanzi (Massachusetts General Hospital, Charlestown, MA, USA). How many genes will be discovered in addition to the known mutations in amyloid precursor protein (APP) (Fig. 1), presenilin (PSEN) 1 and 2, genes and the risk factor gene apolipoprotein E (APOE) allele ε4?
Oct 02,2001 Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo
Arterial conduits are increasingly preferred for surgical bypass because of inherent functional properties conferred by arterial endothelial cells, especially nitric oxide production in response to physiologic stimuli. Here we tested whether endothelial progenitor cells (EPCs) can replace arterial endothelial cells and promote patency in tissue-engineered small-diameter blood vessels (4 mm).
Oct 01,2001

Eukaryotic initiation factor 2B- identification of multiple phosphorylation sites in the -subunit and their functions in vivo

Eukaryatic initiation factor (eIF) 2B is a heterometic guanine nucleotide exchange factor that plays an important role in regulation mRNA translation. Here we identify multiple phosphorylation sites in the largest, catalytic, subunit (ε) of mammalian eIF2B.

更新于2001-10-11